Despite national recommendations for daily vitamin D intake, a new study presented today at the 2017 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) found that just 45.7 percent of patients reported consistently taking vitamin D supplements following a hip fracture, a known treatment and preventative strategy for osteoporosis.
In the U.S., an estimated 44 million people have osteoporosis and another 10 million are at risk for the disease which causes progressive bone loss and increased fracture risk. One in two women and one in four men older than age 50 years will sustain a bone fracture caused by osteoporosis. These potentially debilitating injuries include fractures of the hip, spine, wrist, arm or leg, often occurring from a fall. A bone fracture is often the first sign of the disease which develops slowly with no other symptoms. Treatments, which include medication, weight-bearing exercise, and/or vitamin D, calcium or estrogen supplements, can prevent subsequent fractures.
The U.S. Food and Nutrition Board (FNB) at the Institute of Medicine of The National Academies recommends 600 International Units (IUs) of vitamin D each day for adults, and 800 IUs for Americans age 71 and older.
- Depressive Symptoms Linked to PTSD Post Hip Fracture Repair
- Hip Fracture Surgery: Costs & Benefits
- Overlapping Symptoms and Challenges in Correctly Diagnosing ‘Hip-Spine Syndrome
- Vitamin D May Help Reduce Risk of Acute Respiratory Infection
In this study, Canadian researchers interviewed 573 hip fracture patients about their vitamin D intake during doctor visits for two years following hip fracture surgery. The mean patient age was 74.1, and the majority of patients (66.3 percent) were women.
Less than 50 percent (47.5 percent) of the patients consistently took vitamin D supplements as recommended, 35.6 percent took supplements inconsistently, and less than 19 percent took no supplements. Despite well-developed guidelines and close follow-up in a clinical trial, a low proportion of elderly hip fracture patients are consistently taking vitamin D. This suggests a need to develop and evaluate additional strategies to promote compliance.